Risk factors in the development of stem cell therapy

CA Herberts, MSG Kwa, HPH Hermsen - Journal of translational medicine, 2011 - Springer
Stem cell therapy holds the promise to treat degenerative diseases, cancer and repair of
damaged tissues for which there are currently no or limited therapeutic options. The …

Extracellular vesicles as a drug delivery system: A systematic review of preclinical studies

PEM de Castilla, L Tong, C Huang, AM Sofias… - Advanced drug delivery …, 2021 - Elsevier
During the past decades, extracellular vesicles (EVs) have emerged as an attractive drug
delivery system. Here, we assess their pre-clinical applications, in the form of a systematic …

Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease

M Wernig, JP Zhao, J Pruszak… - Proceedings of the …, 2008 - National Acad Sciences
The long-term goal of nuclear transfer or alternative reprogramming approaches is to create
patient-specific donor cells for transplantation therapy, avoiding immunorejection, a major …

Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient

N Amariglio, A Hirshberg, BW Scheithauer… - PLoS …, 2009 - journals.plos.org
Background Neural stem cells are currently being investigated as potential therapies for
neurodegenerative diseases, stroke, and trauma. However, concerns have been raised over …

[BOOK][B] Everything flows: towards a processual philosophy of biology

DJ Nicholson, J Dupré - 2018 - library.oapen.org
This collection of essays explores the metaphysical thesis that the living world is not
ontologically made up of substantial particles or things, as has often been assumed, but is …

A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential

G Kögler, S Sensken, JA Airey, T Trapp… - The Journal of …, 2004 - rupress.org
Here a new, intrinsically pluripotent, CD45-negative population from human cord blood,
termed unrestricted somatic stem cells (USSCs) is described. This rare population grows …

Stem cell therapy for human neurodegenerative disorders–how to make it work

O Lindvall, Z Kokaia, A Martinez-Serrano - Nature medicine, 2004 - nature.com
Recent progress shows that neurons suitable for transplantation can be generated from
stem cells in culture, and that the adult brain produces new neurons from its own stem cells …

Stem cells in human neurodegenerative disorders—time for clinical translation?

O Lindvall, Z Kokaia - The Journal of clinical investigation, 2010 - Am Soc Clin Investig
Stem cell–based approaches have received much hype as potential treatments for
neurodegenerative disorders. Indeed, transplantation of stem cells or their derivatives in …

Sustained delivery system for stem cell-derived exosomes

AK Riau, HS Ong, GHF Yam, JS Mehta - Frontiers in pharmacology, 2019 - frontiersin.org
Recent literature has ascribed that the paracrine action of stem cells is mediated by
exosomes. Exosomes are nano-sized extracellular vesicles (30 to 100 nm) of endocytic …

Potential risks of bone marrow cell transplantation into infarcted hearts

M Breitbach, T Bostani, W Roell, Y **a… - Blood, The Journal …, 2007 - ashpublications.org
Cellular replacement therapy has emerged as a novel strategy for the treatment of heart
failure. The aim of our study was to determine the fate of injected mesenchymal stem cells …